Octagon Capital Advisors LP Nkarta, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Nkarta, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 240,000 shares of NKTX stock, worth $1.42 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
240,000Holding current value
$1.42 Million% of portfolio
0.41%Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
121Shares Held
52.8MCall Options Held
145KPut Options Held
114K-
Boxer Capital, LLC San Diego, CA5.61MShares$33.1 Million3.15% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.19MShares$30.7 Million1.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.8MShares$22.5 Million0.08% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$22.3 Million12.85% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$21.1 Million2.71% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $288M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...